Activation of Toll-like receptor 5 in microglia modulates their function and triggers neuronal injury.


Journal

Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673

Informations de publication

Date de publication:
10 09 2020
Historique:
received: 08 07 2020
accepted: 29 08 2020
entrez: 11 9 2020
pubmed: 12 9 2020
medline: 1 6 2021
Statut: epublish

Résumé

Microglia are the primary immune-competent cells of the central nervous system (CNS) and sense both pathogen- and host-derived factors through several receptor systems including the Toll-like receptor (TLR) family. Although TLR5 has previously been implicated in different CNS disorders including neurodegenerative diseases, its mode of action in the brain remained largely unexplored. We sought to determine the expression and functional consequences of TLR5 activation in the CNS. Quantitative real-time PCR and immunocytochemical analysis revealed that microglia is the major CNS cell type that constitutively expresses TLR5. Using Tlr5

Identifiants

pubmed: 32912327
doi: 10.1186/s40478-020-01031-3
pii: 10.1186/s40478-020-01031-3
pmc: PMC7488138
doi:

Substances chimiques

Tlr5 protein, mouse 0
Toll-Like Receptor 5 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

159

Références

Neurobiol Aging. 2009 May;30(5):759-68
pubmed: 17905482
Neuro Oncol. 2015 Feb;17(2):200-10
pubmed: 25452390
J Immunol. 2001 Aug 15;167(4):1882-5
pubmed: 11489966
Cell Mol Neurobiol. 2018 Oct;38(7):1349-1368
pubmed: 30117097
Cell Rep. 2019 Dec 10;29(11):3460-3471.e7
pubmed: 31825829
Curr Opin Neurol. 2005 Jun;18(3):315-21
pubmed: 15891419
J Immunol. 2003 May 15;170(10):5165-75
pubmed: 12734364
Clin Sci (Lond). 2011 Nov;121(9):367-87
pubmed: 21745188
Biophys J. 2015 Sep 15;109(6):1214-26
pubmed: 26276688
PLoS One. 2015 May 05;10(5):e0125910
pubmed: 25942007
Alzheimers Dement. 2009 Jul;5(4):348-60
pubmed: 19560105
J Immunol. 2009 May 1;182(9):5641-53
pubmed: 19380811
Glia. 2001 May;34(3):213-28
pubmed: 11329183
Front Cell Neurosci. 2015 Feb 02;9:28
pubmed: 25698933
Infection. 2002 Apr;30(2):104-8
pubmed: 12018467
J Neuropathol Exp Neurol. 2002 Nov;61(11):1013-21
pubmed: 12430718
J Biol Chem. 2010 Jul 9;285(28):21382-90
pubmed: 20452988
J Neuropathol Exp Neurol. 2005 Nov;64(11):991-7
pubmed: 16254493
Nat Immunol. 2006 Aug;7(8):868-74
pubmed: 16829963
Exp Neurobiol. 2017 Aug;26(4):213-226
pubmed: 28912644
Infect Immun. 2008 Oct;76(10):4385-95
pubmed: 18694963
Nature. 2007 Jan 11;445(7124):168-76
pubmed: 17151600
Cell. 2010 Mar 19;140(6):805-20
pubmed: 20303872
Infect Immun. 2000 Oct;68(10):5525-9
pubmed: 10992449
J Neuropathol Exp Neurol. 2005 Sep;64(9):754-62
pubmed: 16141784
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8514-9
pubmed: 12824464
Neurosci Lett. 2009 Mar 27;453(1):41-4
pubmed: 19429012
J Immunol. 2006 May 15;176(10):6194-201
pubmed: 16670329
J Alzheimers Dis. 2015;43(3):957-66
pubmed: 25182736
Nat Immunol. 2010 May;11(5):373-84
pubmed: 20404851
Glia. 2010 Feb;58(3):253-63
pubmed: 19705460
Nature. 2001 Apr 26;410(6832):1099-103
pubmed: 11323673
J Neurosci. 2008 Mar 5;28(10):2320-31
pubmed: 18322079
PLoS One. 2016 Apr 01;11(4):e0152786
pubmed: 27035341
Lancet Neurol. 2015 Apr;14(4):388-405
pubmed: 25792098
J Immunol. 2006 Jul 1;177(1):583-92
pubmed: 16785556
Nature. 2012 Sep 20;489(7416):391-399
pubmed: 22996553
Brain Behav Immun. 2016 Nov;58:338-347
pubmed: 27554518
Cell Rep. 2016 Oct 18;17(4):1128-1140
pubmed: 27760316
Nat Med. 2015 Nov;21(11):1326-31
pubmed: 26479925
Nat Rev Immunol. 2009 Jun;9(6):429-39
pubmed: 19461673
FASEB J. 2004 Feb;18(2):412-4
pubmed: 14688201
J Biol Chem. 2006 Jul 7;281(27):18560-8
pubmed: 16644730
J Neuropathol Exp Neurol. 2016 May;75(5):429-40
pubmed: 27030742
J Immunol. 2004 Sep 15;173(6):3916-24
pubmed: 15356140
J Neurochem. 1999 May;72(5):2215-8
pubmed: 10217305
Science. 2012 Feb 17;335(6070):859-64
pubmed: 22344444
Brain Struct Funct. 2016 Mar;221(2):1157-72
pubmed: 25523105
J Neurosci. 2007 Nov 21;27(47):13033-41
pubmed: 18032677
Infect Immun. 2005 Apr;73(4):2344-50
pubmed: 15784580
Elife. 2020 Jan 28;9:
pubmed: 31989925
J Neurosci. 2002 Apr 1;22(7):2478-86
pubmed: 11923412
Transl Psychiatry. 2017 May 9;7(5):e1120
pubmed: 28485733
Glia. 2013 Apr;61(4):539-49
pubmed: 23355222
J Biol Chem. 2019 Aug 30;294(35):12921-12932
pubmed: 31296663
J Immunol. 2001 Jan 15;166(2):1248-60
pubmed: 11145708
Nat Neurosci. 2016 Jan;19(1):20-7
pubmed: 26713745
J Immunol. 2007 May 15;178(10):6476-81
pubmed: 17475877
Surg Neurol. 2000 Jan;53(1):86-90
pubmed: 10697239
J Neuroinflammation. 2011 Aug 04;8:90
pubmed: 21816039
J Exp Med. 2018 Sep 3;215(9):2247-2264
pubmed: 30158114
Nat Neurosci. 2012 Jun;15(6):827-35
pubmed: 22610069
Nat Rev Microbiol. 2017 Mar;15(3):149-159
pubmed: 28090076
Mol Neurobiol. 2019 Sep;56(9):6539-6550
pubmed: 30852796
Curr Top Microbiol Immunol. 2009;336:105-20
pubmed: 19688330
Biotechniques. 2010 Feb;48(2):121-4
pubmed: 20359295
Acta Neuropathol Commun. 2019 Feb 14;7(1):20
pubmed: 30764877

Auteurs

Masataka Ifuku (M)

Cellular Neuroscience, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.

Lukas Hinkelmann (L)

Institute of Cell Biology and Neurobiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Leonard D Kuhrt (LD)

Cellular Neuroscience, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Ibrahim E Efe (IE)

Cellular Neuroscience, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Victor Kumbol (V)

Institute of Cell Biology and Neurobiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Alice Buonfiglioli (A)

Cellular Neuroscience, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Institute of Cell Biology and Neurobiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Christina Krüger (C)

Institute of Cell Biology and Neurobiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Philipp Jordan (P)

Cellular Neuroscience, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.

Marcus Fulde (M)

Institute of Microbiology and Epizootics, Centre for Infection Medicine, Freie Universität Berlin, Berlin, Germany.

Mami Noda (M)

Laboratory of Pathophysiology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.

Helmut Kettenmann (H)

Cellular Neuroscience, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.

Seija Lehnardt (S)

Institute of Cell Biology and Neurobiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. seija.lehnardt@charite.de.
Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. seija.lehnardt@charite.de.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH